adding avastin to tarceva help egfr positive lung cancer patients?
Published 10 years ago • 1.4K plays • Length 9:26Download video MP4
Download video MP3
Similar videos
-
7:48
should avastin be added to egfr tki therapy for egfr mutation-positive nsclc?
-
1:02
are egfr tkis (such as tarceva) effective in lung cancer patients who are wild type egfr?
-
2:47
treating egfr patients after tarceva stops working
-
9:11
asco 2018 - tarceva or tarceva with avastin as 1st line for egfr pos. nsclc vs. tagrisso or vizimpro
-
8:16
does gilotrif help egfr positive lung cancer patients?
-
12:50
avastin-containing regimen for first line and maintenance therapy in advanced nsclc
-
1:38
ecog1505: will avastin be treatment for early stage lung cancer patients?
-
1:43
erlotinib prevent disease recurrence in early stage egfr positive nsclc patients?
-
17:45
individual treatments for individual egfr mutations
-
33:47
gracecast-049_lung-cancer_weiss on egfr therapy for early stage nsclc
-
7:22
debating egfr inhibitors for squamous cell lung cancer patients
-
4:57
adding to targeted therapy: current statistics and biology - targeted therapies in lung cancer 2023
-
3:15
how do we make egfr inhibitors work better for patients
-
4:17
how should we integrate new immunotherapies into treatment strategies for lung cancer?
-
6:38
gracecastuc-005 - the topical study: is rash a predictor of benefit with egfr inhibitor therapy?
-
4:10
3rd generation drug for acquired resistance in egfr lung cancer
-
7:59
dacomitinib beats iressa as first line treatment for egfr mutation-positive nsclc
-
16:43
radiant and select: is adjuvant erlotinib effective in early-stage lung cancer?
-
5:51
how do we approach acquired resistance to targeted therapies in lung cancer?